Search

everythinglearnresearchcommunity

for

Search:↓

A patient with alopecia areata regrew hair after taking tofacitinib and showed changes in certain blood and skin markers.

Tofacitinib effectively treated a woman's severe symptoms from a rare autoimmune condition.

Baricitinib improved hair loss and arthritis in a lupus patient.

Ivarmacitinib significantly improved hair regrowth in severe alopecia areata after tofacitinib was less effective.

Tofacitinib improved hair loss and skin symptoms in a patient after secukinumab caused hair loss.

Infliximab was effective in treating a scalp condition that did not respond to other treatments.

Ritlecitinib effectively regrows hair in severe alopecia areata and is well tolerated.

Tofacitinib helps improve skin conditions in people with Down syndrome, especially alopecia areata.

Tofacitinib was more effective than apremilast in treating hair loss in a mouse model of alopecia areata.

Tildrakizumab showed limited effectiveness in treating chronic alopecia areata in a small group of patients.

ASLAN004 was safe and well-tolerated, supporting further development for treating certain diseases.

Combining ficlatuzumab and gefitinib can cause severe scarring hair loss.

Tofacitinib helped psoriasis but not alopecia universalis, needing more research.

Low-dose tofacitinib is effective and cheaper for severe alopecia areata.

Tofacitinib successfully treated vitiligo in a patient with lupus without side effects.

Two new IRAK4-inhibitors effectively reduced skin inflammation and immune response markers in healthy volunteers.

Tofacitinib effectively treated severe hair loss in a patient who didn't respond to other treatments.

Tofacitinib is effective and safe for treating severe alopecia areata and related conditions.

Tofacitinib helped most patients with alopecia areata regrow hair and changes in immune cells were linked to the treatment's effectiveness.

JAK inhibitors may effectively treat lichen planopilaris and frontal fibrosing alopecia with minimal side effects.

Baricitinib might help treat hair loss in lupus patients, but more research is needed.

Tofacitinib is a safe treatment for hair loss in children, but long-term use may be needed for best results.

Tofacitinib treatment significantly improved a patient's psoriasis, psoriatic arthritis, and alopecia universalis.

Tofacitinib may help hair regrowth in familial alopecia areata with immune issues, but more research is needed.

Infliximab successfully treated a severe hair loss case in Sri Lanka.

Interferon, especially alfa interferon, is an effective treatment for cutaneous T-cell lymphoma with manageable side effects.

Tofacitinib, a JAK inhibitor, improved hair regrowth in most patients with severe alopecia areata and had minimal side effects.

Anifrolumab helped some lupus patients reduce steroid use, but safety concerns remain.

Tofacitinib helped improve symptoms and hair growth in a patient with Aicardi-Goutières syndrome.

Ixekizumab helps improve life quality, physical ability, and work performance in patients with psoriatic arthritis who haven't used biologic drugs before.